Company / Current Liabilities per Share
ABEONA THERAPEUTICS INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.65
FY2025
5-year range
$0.17 / $1.32
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share returned to growth in FY2025 after 2 years of decline, reaching $0.65.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of +5.2%.
Improved from $0.76 to $0.65 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -21.1%
- 5-Year CAGR
- +5.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 3.6% year-over-year.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | +3.6% |
| FY2024 | $0.63 | -17.4% |
| FY2023 | $0.76 | -42.7% |
| FY2022 | $1.32 | +664.0% |
| FY2021 | $0.17 | -65.5% |
| FY2020 | $0.50 | -37.8% |
| FY2019 | $0.81 | +86.0% |
| FY2018 | $0.43 | +211.7% |
| FY2017 | $0.14 | -53.7% |
| FY2016 | $0.30 | -60.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026